Cranbury, NJ, United States of America

Robert Swanson

This inventor holds 2 USPTO granted patents. Top assignees: Pharmacopeia Drug Discovery, Inc., Pharmacopeia Inc.. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Swanson. Retrieved from https://idiyas.com/inventor/robert-swanson-1vjlz38a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Robert Swanson

Introduction

Robert Swanson, an accomplished inventor based in Cranbury, NJ, has made significant contributions to the field of biomedical science through his innovative research and development. With a total of two patents to his name, his work revolves around the cloning and characterization of receptors and their potential therapeutic applications.

Latest Patents

Swanson's latest patents include groundbreaking methodologies for identifying modulators of receptor activity using orthologues of human receptors. This work encompasses methods for screening potential therapeutic agents through the identification of suitable animal models. His research delves into the genes for bradykinin B receptors from various mammalian species, including vervet monkeys, rhesus macaques, tree shrews, dogs, and pigs. Additionally, he has cloned and characterized genes for CXCR2 receptors from diverse primates such as chimpanzees, gorillas, and orangutans.

Another noteworthy patent involves the cloning and characterization of genes encoding bradykinin B1 receptor homologues, contributing to a deeper understanding of their nucleotide and amino acid sequences. This advancement aids in the identification of modulators for bradykinin B receptor activity, further emphasizing the potential of these studies in therapeutic applications.

Career Highlights

Throughout his career, Swanson has played a pivotal role in the development of pharmaceutical innovations. He has worked with reputable companies such as Pharmacopeia Inc. and Pharmacopeia Drug Discovery, Inc., where his expertise in receptor biology and drug development was integral to the advancement of new therapeutic strategies. His commitment to innovation has positioned him as a leading figure in the exploration of receptor activities and their modulation.

Collaborations

Swanson's success can also be attributed to his collaborative efforts with esteemed colleagues like Maria Webb and Barbara Strohl. Together, they have pushed the boundaries of research and development, creating a synergistic environment that fosters creativity and innovation in the biomedical field.

Conclusion

In summary, Robert Swanson's contributions to the field of receptor biology, particularly through his recent patents, demonstrate his dedication to advancing scientific knowledge and therapeutic applications. His collaborations and career achievements reflect his significant impact on the pharmaceutical industry and showcase the potential for ongoing innovations derived from his research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…